바이오로직스 자료
Key considerations to ensure product stability and patient safety in aseptic fill/finish manufacturing
As the demand for aseptic fill/finish (F/F) manufacturing continues to grow, so too does the importance of engaging CDMO partners who harness the right capabilities and expertise to ensure product stability and patient safety. In this whitepaper, John Thomas, Director of Drug Product MSAT, details how Samsung Biologics’ dedicated and experienced DP MSAT team provides end-to-end F/F services, while maintaining business continuity and insulating clients against supply shortages.
As the demand for aseptic fill/finish (F/F) manufacturing continues to grow, so too does the importance of engaging CDMO partners who harness the right capabilities and expertise to ensure product stability and patient safety. In this whitepaper, John Thomas, Director of Drug Product MSAT, details how Samsung Biologics’ dedicated and experienced DP MSAT team provides end-to-end F/F services, while maintaining business continuity and insulating clients against supply shortages.